Sign in to continue:

Wednesday, February 11th, 2026

Day: January 4, 2026

2026 Market Snapshot: Key Themes, Risks, and Opportunities

Macro & Rates Outlook Futures markets are currently pricing in two quarter-point interest rate cuts in 2026, providing a potential tailwind for equities. Despite optimism, stocks are expensive. Bank of America strategist Savita Subramanian...

Japanese Pachinko & Real Estate Company IPO: Business Model, Market Strategies, and Investment Highlights for 2025

Libera IPO Analysis June 2025: Investment Opportunity, Financials, and Growth Outlook Libera Date of prospectus: June 2025 Libera IPO: High-Growth Japanese Tech Play Targets Nasdaq – Key Risks, Upside, and Investment Facts Libera, a...

Jinxun Group Hong Kong IPO: Global Copper & Cobalt Leader, ESG, Financials & Growth Strategy Explained

Yunnan Jinxun Resources Co., Ltd. IPO Analysis: Investor-Grade Deep Dive Yunnan Jinxun Resources Co., Ltd. Date of Prospectus: December 31, 2025 Yunnan Jinxun Resources: HKEX IPO Analysis, Cornerstone Investors, Offer Structure, and First-Day Listing...

Suzhou Ribo Life Science IPO: Leading the Future of siRNA Oligonucleotide Therapeutics – Company Overview, Pipeline, and Competitive Edge 1116272278

Suzhou Ribo Life Science Co., Ltd. IPO: Investor Analysis & Outlook Suzhou Ribo Life Science Co., Ltd. Date of prospectus: December 31, 2025 Suzhou Ribo Life Science IPO: In-Depth Analysis, Investor Insights & Listing...

MiniMax AI: Global Leader in Scalable Multi-Modal Foundation Models, Video Generation, and AI-Native Products

MiniMax Limited IPO Analysis: Comprehensive Investor Guide MiniMax Limited Date of Prospectus: December 31, 2025 MiniMax Limited IPO: A Deep Dive into the Largest AI Foundation Model Listing in Hong Kong MiniMax Limited, a...

Suzhou Ribo Life Science Co., Ltd. Global Offering: Hong Kong IPO Details, Application Process & Key Dates for 2026 2

Suzhou Ribo Life Science Co., Ltd. IPO Analysis: Comprehensive Investor Insights Company: Suzhou Ribo Life Science Co., Ltd. Date of Prospectus: December 31, 2025 Suzhou Ribo Life Science Co., Ltd. IPO: Detailed Analysis of...

Yunnan Jinxun Resources Co., Ltd. Global Offering: Key Dates, Application Process & IPO Details (Stock Code: 3636) 2

Yunnan Jinxun Resources Co., Ltd. IPO Analysis – 2025/2026 Hong Kong Listing Deep Dive Yunnan Jinxun Resources Co., Ltd. Date of prospectus: December 31, 2025 Yunnan Jinxun Resources Co., Ltd. Launches Hong Kong IPO:...

MiniMax Group Inc. Announces Hong Kong IPO: Key Dates, Offer Details & Application Guide for 2026 Listing 2610

MiniMax Group Inc. Launches Landmark Hong Kong IPO: Key Details, Structure, and Investor Insights MiniMax Group Inc., a Cayman Islands-incorporated company controlled through weighted voting rights, is set to launch its highly anticipated initial...

Edge Medical: China’s Leading Surgical Robot Innovator – Products, Market Strategy, and Competitive Advantages Explained

Shenzhen Edge Medical Co., Ltd. IPO Analysis – Robust Investor Overview Shenzhen Edge Medical Co., Ltd. Date of Prospectus: December 30, 2025 Shenzhen Edge Medical’s Landmark Hong Kong IPO: Investor Analysis, Financials, and Strategic...

Shenzhen Edge Medical Co., Ltd. Announces HKEX Global Offering: Key Dates, Application Process & IPO Details for 2026 2 5 6

Shenzhen Edge Medical Co., Ltd. IPO Analysis – Comprehensive Investor Overview Company Name: Shenzhen Edge Medical Co., Ltd. Date of Prospectus: December 30, 2025 Shenzhen Edge Medical Co., Ltd. Launches Hong Kong IPO: Investor...